Literature DB >> 31012935

Association of State Medicaid Expansion Status With Low Birth Weight and Preterm Birth.

Clare C Brown1, Jennifer E Moore2,3, Holly C Felix1, M Kathryn Stewart1, T Mac Bird1, Curtis L Lowery4, J Mick Tilford1.   

Abstract

Importance: Low birth weight and preterm birth are associated with adverse consequences including increased risk of infant mortality and chronic health conditions. Black infants are more likely than white infants to be born prematurely, which has been associated with disparities in infant mortality and other chronic conditions. Objective: To evaluate whether Medicaid expansion was associated with changes in rates of low birth weight and preterm birth outcomes, both overall and by race/ethnicity. Design, Setting, and Participants: Using US population-based data from the National Center for Health Statistics Birth Data Files (2011-2016), difference-in-differences (DID) and difference-in-difference-in-differences (DDD) models were estimated using multivariable linear probability regressions to compare birth outcomes among infants in Medicaid expansion states relative to non-Medicaid expansion states and changes in relative disparities among racial/ethnic minorities for singleton live births to women aged 19 years and older. Exposures: State Medicaid expansion status and racial/ethnic category. Main Outcomes and Measures: Preterm birth (<37 weeks' gestation), very preterm birth (<32 weeks' gestation), low birth weight (<2500 g), and very low birth weight (<1500 g).
Results: The final sample of 15 631 174 births (white infants: 8 244 924, black infants: 2 201 658, and Hispanic infants: 3 944 665) came from the District of Columbia and 18 states that expanded Medicaid (n = 8 530 751) and 17 states that did not (n = 7 100 423). In the DID analyses, there were no significant changes in preterm birth in expansion relative to nonexpansion states (preexpansion to postexpansion period, 6.80% to 6.67% [difference: -0.12] vs 7.86% to 7.78% [difference: -0.08]; adjusted DID: 0.00 percentage points [95% CI, -0.14 to 0.15], P = .98), very preterm birth (0.87% to 0.83% [difference: -0.04] vs 1.02% to 1.03% [difference: 0.01]; adjusted DID: -0.02 percentage points [95% CI, -0.05 to 0.02], P = .37), low birth weight (5.41% to 5.36% [difference: -0.05] vs 6.06% to 6.18% [difference: 0.11]; adjusted DID: -0.08 percentage points [95% CI, -0.20 to 0.04], P = .20), or very low birth weight (0.76% to 0.72% [difference: -0.03] vs 0.88% to 0.90% [difference: 0.02]; adjusted DID: -0.03 percentage points [95% CI, -0.06 to 0.01], P = .14). Disparities for black infants relative to white infants in Medicaid expansion states compared with nonexpansion states declined for all 4 outcomes, indicated by a negative DDD coefficient for preterm birth (-0.43 percentage points [95% CI, -0.84 to -0.02], P = .05), very preterm birth (-0.14 percentage points [95% CI, -0.26 to -0.02], P = .03), low birth weight (-0.53 percentage points [95% CI, -0.96 to -0.10], P = .02), and very low birth weight (-0.13 percentage points [95% CI, -0.25 to -0.01], P = .04). There were no changes in relative disparities for Hispanic infants. Conclusions and Relevance: Based on data from 2011-2016, state Medicaid expansion was not significantly associated with differences in rates of low birth weight or preterm birth outcomes overall, although there were significant improvements in relative disparities for black infants compared with white infants in states that expanded Medicaid vs those that did not.

Entities:  

Mesh:

Year:  2019        PMID: 31012935      PMCID: PMC6487545          DOI: 10.1001/jama.2019.3678

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  26 in total

1.  Impacts of Medicaid Expansion on Health Among Women of Reproductive Age.

Authors:  Claire E Margerison; Colleen L MacCallum; Jiajia Chen; Yasamean Zamani-Hank; Robert Kaestner
Journal:  Am J Prev Med       Date:  2019-11-21       Impact factor: 5.043

2.  Capsule Commentary on Gordon et al., The Impact of Medicaid Expansion on Continuous Enrollment: a Two-State Analysis.

Authors:  Erin Brantley
Journal:  J Gen Intern Med       Date:  2019-09       Impact factor: 5.128

3.  Medicaid expansion and infant mortality, revisited: A difference-in-differences analysis.

Authors:  Alexandra Wiggins; Ibraheem M Karaye; Jennifer A Horney
Journal:  Health Serv Res       Date:  2020-03-20       Impact factor: 3.402

4.  Impacts of Medicaid Expansion Before Conception on Prepregnancy Health, Pregnancy Health, and Outcomes.

Authors:  Claire E Margerison; Robert Kaestner; Jiajia Chen; Colleen MacCallum-Bridges
Journal:  Am J Epidemiol       Date:  2021-08-01       Impact factor: 4.897

5.  Pregnancy Medicaid Improvements in a Nonexpansion State After the Affordable Care Act.

Authors:  Jonas J Swartz; Joseph Meskey; Gretchen S Stuart; Maria I Rodriguez
Journal:  Ann Fam Med       Date:  2021 Jan-Feb       Impact factor: 5.166

6.  Postpartum Medicaid Extension to Address Racial Inequity in Maternal Mortality.

Authors:  Natasha R Kumar; Ann Borders; Melissa A Simon
Journal:  Am J Public Health       Date:  2021-02       Impact factor: 9.308

7.  Association of State Medicaid Expansion Status With Hypertensive Disorders of Pregnancy in a Singleton First Live Birth.

Authors:  Ian K Everitt; Priya M Freaney; Michael C Wang; William A Grobman; Matthew J O'Brien; Lindsay R Pool; Sadiya S Khan
Journal:  Circ Cardiovasc Qual Outcomes       Date:  2022-01-18

8.  Geographic variation in Alzheimer's disease mortality.

Authors:  Michael Topping; Jinho Kim; Jason Fletcher
Journal:  PLoS One       Date:  2021-07-01       Impact factor: 3.240

Review 9.  Hypertensive Disorders of Pregnancy.

Authors:  Apurva M Khedagi; Natalie A Bello
Journal:  Cardiol Clin       Date:  2020-11-02       Impact factor: 2.213

10.  Medicaid expansion and infant mortality: the (questionable) impact of the Affordable Care Act.

Authors:  Amanda Cook; Amanda Stype
Journal:  J Epidemiol Community Health       Date:  2020-09-10       Impact factor: 3.710

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.